Cited by 610Ovarian function and disordersEndometriosis Research and TreatmentReproductive Biology and Fertility

Update on PCOS: consequences, challenges, and guiding treatment

Open access
Hoeger, Kathleen M, Dokras, Anuja, Piltonen, Terhi·2021·The Journal of Clinical Endocrinology & Metabolism

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common reproductive endocrine disorders in women and despite this, diagnostic challenges, delayed diagnosis, and less-than-optimal treatment regimens plague the condition. The International PCOS network, consisting of geographically diverse international experts in PCOS as well as consumers, engaged in a multi-year international evidence-based guideline development process that was jointly sponsored by the European Society for Human Reproduction and Embryology (ESHRE) and the American Society of Reproductive Medicine (ASRM). The guideline was published in 2018 and endorsed by more than 40 international societies involved in PCOS. Translation of this evidence-based guideline to medical practice and consumer groups remains a priority. However, there remain many challenges to both understanding the diagnosis and treatment of PCOS. Evidence suggests that both clinicians and consumers are not satisfied with the timeliness of diagnosis and treatment options. This review summarizes the important findings for diagnosis and treatment from the guidelines and expands on recent developments in the literature since its publication. Special attention to diagnosis at the ends of the reproductive spectrum are discussed and remaining areas of controversy are noted. Additionally, the review highlights some of the remaining challenges in the understanding and management of PCOS to help guide clinicians and investigators in this perplexing condition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgaa839

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Screening for these conditions is recommended by numerous guidelines to improve well-being, ability to successfully implement and sustain lifestyle changes and manage PCOS.

    “Screening for these conditions is recommended by numerous guidelines to improve well-being, ability to successfully implement and sustain lifestyle changes and manage PCOS.”

    From 'I'm usually being my own doctor': women's experiences of managing polycystic ovary syndrome in Canada (2023) · cites this paper as [20]

    The Management section recommends systematic screening for psychological distress in women with PCOS, and the Behavioral/emotional section links eating disorders and body-image distress to difficulty losing weight. The Lifestyle interventions section also associates higher depressive indices with program attrition. The paper does not establish that screening itself improves well-being, sustained lifestyle changes, or PCOS management, nor does it identify numerous guidelines making that full recommendation. Page numbers were not available in our copy. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Evidence indicates that the advice and support for diet-lifestyle management is not consistently provided and may not meet the needs of patients.

    “However, evidence indicates that the advice and support for diet-lifestyle management is not consistently provided and may not meet the needs of patients [32].”

    From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [32]

    The Abstract (page not available) reports that women with PCOS are dissatisfied with the treatment and recommendations they receive. The Lifestyle interventions section suggests adding behavioral support, but neither passage establishes that diet-lifestyle advice and support are inconsistently provided or specifically fail to meet patients’ needs. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Recent studies including surveys, interviews, and focus groups of those with PCOS reveal a high degree of dissatisfaction with health care and the health care system in many countries.

    “Recent studies including surveys, interviews, and focus groups of those with PCOS reveal a high degree of dissatisfaction with health care and the health care system in many countries [2, 28, 30–34].”

    From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [32]

    The review’s Abstract (page not provided) says women with PCOS report dissatisfaction with the treatment and recommendations they receive, supporting the core point about dissatisfaction with care. Our copy does not establish that surveys, interviews and focus groups found a high degree of dissatisfaction with health care systems in many countries. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Our findings reinforce other findings in Canada and as well as other countries related to the health care experience of those with PCOS.

    “Our findings reinforce other findings in Canada and as well as other countries related to the health care experience of those with PCOS [2, 30–32, 34, 46].”
  • Pharmaceuticals such as metformin, lipid-lowering agents and oral contraceptives should be tailored to the individual patient's risk profile and treatment goals.

    “Pharmaceuticals such as metformin, lipid-lowering agents and oral contraceptives should be tailored to the individual patient's risk profile and treatment goals.10,13,19,20”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hoeger, K. M., Dokras, A., & Piltonen, T.
Affiliations
  • University of Rochester Medicine (US)
  • University of Pennsylvania (US)
  • Oulu University Hospital (FI)
Corresponding author
Hoeger, Kathleen M
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2020-11-19
Volume
106
Issue
3
Pages
e1071-e1083
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W3104254993
Cited by
610
References
107
Citations by year
2026: 105 · 2025: 125 · 2024: 160 · 2023: 127 · 2022: 77 · 2021: 16
FWCI
8.11
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
Novo Nordisk Fonden (NNF21OC0070372)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
Keywords
polycystic ovary syndrome, PCOS diagnosis, PCOS treatment, evidence-based clinical guidelines, delayed diagnosis, reproductive endocrine disorders
MeSH terms
Diagnostic Techniques, Endocrine, Female, Humans, Infertility, Female, Metabolic Diseases, Polycystic Ovary Syndrome, Practice Guidelines as Topic, Reproductive Medicine, Delayed Diagnosis, Time-to-Treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review